A New Way to Screen for Cervical Cancer: FDA Approves At-Home HPV Test

In a major step forward for women’s health, the FDA has approved a new at-home tool that allows patients to collect a sample for HPV testing—as a part of screening for cervical cancer.
What Is It?
The device, known as the Teal Wand, is designed to make cervical cancer screening easier and more comfortable for women. It’s similar in shape to a tampon applicator and includes a soft tip to gently collect cells from the vaginal canal. Once the sample is collected, it can be mailed to a lab for testing.
Is It Effective?
Early clinical studies show that the at-home test is highly accurate in detecting high-risk strains of HPV, the primary cause of cervical cancer. Most users also found the device easy to use, and the majority of samples returned valid results.
What It Doesn’t Replace
While this tool is a powerful step forward, it doesn’t eliminate the need for in-person yearly gynecological care. Also, women with abnormal results or symptoms still need follow-up exams, and this device is currently intended for women aged 25–65 at average risk.
Our View
At John Labban, M.D., PC – Women’s Health, we support innovations that improve access and empower women to take control of their health. However, the Teal Wand does not replace traditional exams, but it can help more women begin the screening process sooner and with more comfort. We worry that some women might consider this at-home HPV test is enough for their well being and not come for their annual exam. If you are intending to use this test, make sure it is covered by your insurance.



